Retrieved from Bezin, J., Gouverneur, A., Pnichon, M., et al
Semaglutide medications like Ozempic and Wegovy can help people lose about 5%15% of their body weight over roughly a year to a year and a half
MARKET TRENDS IN GLP-1 USAGE Recent market data suggest that around 5% of US adults (approximately 12.5 million people) have used or are currently using GLP-1s for weight loss alone.3 This is higher than the 7.4 million4 people (both adults and children) using insulin and equal to the 5% who have used or are currently using GLP-1s solely to treat a chronic condition such as diabetes or heart disease approximately 3% are using GLP-1s to both treat a chronic condition and to lose weight
Most patients who have type II diabetes or prediabetes will get coverage from their health insurance plans
One caveat the headlines miss: Category 1 reclassification is not FDA approval
Over a thousand individuals, including medical professionals, celebrities, and the general public, have travelled from around the world to experience their weight-loss treatment